首页|院内制剂降脂胶囊治疗颈动脉粥样硬化斑块患者的疗效及对血液流变学的影响分析

院内制剂降脂胶囊治疗颈动脉粥样硬化斑块患者的疗效及对血液流变学的影响分析

扫码查看
目的 分析遵义市中医院院内制剂降脂胶囊治疗颈动脉粥样硬化斑块患者的疗效及对血液流变学的影响.方法 选取 252 例颈动脉粥样硬化斑块患者,按随机数字表法分为普通组与自制组,每组 126 例.普通组常规给予阿托伐他汀治疗,自制组在普通组用药基础上加用院内制剂降脂胶囊开展治疗.比较两组颈动脉斑块情况[斑块体积(PV)、颈动脉内膜-中层厚度(IMT)及Crouse积分]、血脂指标[总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)及高密度脂蛋白胆固醇(HDL-C)]、实验室指标[超敏C反应蛋白(hs-CRP)、低密度脂蛋白受体相关蛋白-6(LRP-6)]及血液流变学指标.结果 自制组用药后PV(45.33±1.74)mm3、IMT(1.08±0.13)mm及Crouse积分(4.72±0.36)分均低于普通组的(57.26±2.45)mm3、(1.52±0.19)mm、(5.34±0.42)分(P<0.05).自制组用药后TC(3.17±0.42)mmol/L、TG(1.24±0.27)mmol/L及LDL-C(1.39±0.20)mmol/L均低于普通组的(4.01±0.76)、(1.60±0.29)、(2.03±0.35)mmol/L,HDL-C(1.73±0.25)mmol/L显著高于普通组的(1.32±0.13)mmol/L(P<0.05).自制组用药后hs-CRP水平(4.13±0.52)mg/L低于普通组的(7.58±1.06)mg/L,LRP-6 水平(15.67±2.34)ng/ml高于普通组的(12.33±2.01)ng/ml(P<0.05).自制组用药后全血高切粘度(4.72±0.83)mPa·s、全血低切粘度(9.02±1.71)mPa·s及血浆粘度(1.52±0.18)mPa·s均低于普通组的(6.12±1.81)、(10.31±1.48)、(1.73±0.16)mPa·s(P<0.05).结论 院内制剂降脂胶囊用于颈动脉粥样硬化斑块患者临床治疗中具有确切疗效,可显著改善其血液流变学.
Analysis of efficacy of in-hospital preparations of Jiangzhi capsules in the treatment of patients with carotid atherosclerotic plaque and its influence on blood rheology
Objective To analyze the efficacy of in-hospital preparations of Jiangzhi capsules in the treatment of patients with carotid atherosclerotic plaque and its influence on blood rheology.Methods A total of 252 patients with carotid atherosclerotic plaque were selected and divided into an ordinary group and a self-made group according to random numerical table,with 126 cases in each group.The ordinary group was treated with atorvastatin,and the self-made group was treated with in-hospital preparations of Jiangzhi capsules based on the ordinary group.Comparison was made on carotid plaque[plaque volume(PV),carotid intima-media thickness(IMT),and Crouse score],blood lipid indicators[total cholesterol(TC),triglycerides(TG),low-density lipoprotein cholesterol(LDL-C),and high-density lipoprotein cholesterol(HDL-C)],laboratory indicators[hypersensitivity C-reactive protein(hs-CRP),low-density lipoprotein receptor associated protein-6(LRP-6)],and hemorheological parameters between the two groups.Results After medication,the self-made group had PV of(45.33±1.74)mm3,IMT of(1.08±0.13)mm and Crouse score of(4.72±0.36)points,which were lower than(57.26±2.45)mm3,(1.52±0.19)mm and(5.34±0.42)points in the ordinary group(P<0.05).After medication,the self-made group had TC of(3.17±0.42)mmol/L,TG of(1.24±0.27)mmol/L and LDL-C of(1.39±0.20)mmol/L,which were lower than(4.01±0.76),(1.60±0.29)and(2.03±0.35)mmol/L in the ordinary group;the self-made group had significantly higher HDL-C of(1.73±0.25)mmol/L than(1.32±0.13)mmol/L in the ordinary group(P<0.05).After medication,the self-made group had lower hs-CRP of(4.13±0.52)mg/L than(7.58±1.06)mg/L in the ordinary group,and higher LRP-6 of(15.67±2.34)ng/ml than(12.33±2.01)ng/ml in the ordinary group(P<0.05).After medication,the self-made group had whole blood high shear viscosity of(4.72±0.83)mPa·s,whole blood low shear viscosity of(9.02±1.71)mPa·s and plasma viscosity of(1.52±0.18)mPa·s,which were lower than(6.12±1.81),(10.31±1.48)and(1.73±0.16)mPa·s in the ordinary group(P<0.05).Conclusion In-hospital preparation of Jiangzhi capsule has definite curative effect in the treatment of patients with carotid atherosclerotic plaque in clinic,and can significantly improve their hemorheology.

In-hospital preparationsJiangzhi capsulesCarotid atherosclerotic plaqueHemorheologyLipid metabolismLow density lipoprotein receptor-associated protein-6

姜雄、陈军、王海燕、苟明琴、罗均

展开 >

563000 遵义市中医院脑病科

院内制剂 降脂胶囊 颈动脉粥样硬化斑块 血液流变学 血脂代谢 低密度脂蛋白受体相关蛋白-6

遵义市科技计划

遵市科合支撑HZ字2020186号

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(9)
  • 15